...
机译:HER1和HER2在腹膜,卵巢和大肠子宫内膜异位症和卵巢子宫内膜样腺癌中的状态
Research Translational Laboratory Histocytopathology Unit Institute Gustave Roussy 39 rue Camille Desmoulins 94805 Villejuif France;
Obstetrics and Gynecology Department Tenon Hospital 75020 Paris France;
Research Translational Laboratory Histocytopathology Unit Institute Gustave Roussy 39 rue Camille Desmoulins 94805 Villejuif France;
Obstetrics and Gynecology Department Institute Alix de Champagne 51092 Reims France;
Obstetrics and Gynecology Department Tenon Hospital 75020 Paris France;
Obstetrics and Gynecology Department Tenon Hospital 75020 Paris France;
Research Translational Laboratory Histocytopathology Unit Institute Gustave Roussy 39 rue Camille Desmoulins 94805 Villejuif France;
Endometriosis; HER; Endometrioid ovarian cancer; Immunohistochemistry; Fluorescent in situ hybridisation;
机译:HER1和HER2在腹膜,卵巢和大肠子宫内膜异位症和卵巢子宫内膜样腺癌中的状态。
机译:与性腺外子宫内膜异位症相比,卵巢子宫内膜异位症的染色体畸变频率更高:可能与子宫内膜样腺癌有关
机译:卵巢子宫内甲状腺异质腺癌中的不同分子途径,并发细胞异位症
机译:减少非非典型,非典型子宫内膜异位症囊肿和卵巢透明细胞癌中的ARID1a表达,作为恶性转化的生物标志物
机译:Wnt信号通路缺陷在卵巢子宫内膜样腺癌发病机理中的作用
机译:一名24岁的患者没有诊断出在子宫内膜异位症中产生的双侧卵巢剂腺癌腺癌的前肢前病病史
机译:用卵巢剂腺癌腺癌同时由乙状胺结肠子宫内膜异位症产生的子宫内膜异质腺癌的情况